Back to top
more

Edwards Lifesciences (EW)

(Delayed Data from NYSE)

$65.81 USD

65.81
5,087,779

-0.89 (-1.33%)

Updated Nov 12, 2024 04:00 PM ET

After-Market: $65.81 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (66 out of 249)

Industry: Medical - Instruments

Zacks News

Edwards Lifesciences (EW) Q4 Earnings In Line, Revenues Top

Edwards Lifesciences (EW) Q4 results benefit from growth in all the businesses.

Edwards Lifesciences (EW) Q4 Earnings Meet Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 0.00% and 0.41%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Medical Products' Earnings Lineup for Jan 31: EW, BAX & More

Let's take a look at the factors that are likely to influence the earnings results of a few Medical Products bigwigs within the broader Medical space.

What's in Store for Edwards Lifesciences' (EW) Q4 Earnings?

Edwards Lifesciences (EW) expected to see consistent performance by Surgical Structural Heart and Critical Care segments in Q4.

Edwards Lifesciences (EW) Reports Next Week: Wall Street Expects Earnings Growth

Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Can Edwards Lifesciences (EW) Keep the Earnings Surprise Streak Alive?

Edwards Lifesciences (EW) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Walgreens (WBA) Q1 Earnings Gain From Overall Strength?

Several planned developments, early benefits from new pharmacy contracts as well as increased volumes are consistently driving growth within Walgreens Boots' (WBA) Retail Pharmacy USA division.

Edwards Lifesciences Advances in AI With Bay Labs Tie-Up

Through the tie-up, Edwards Lifesciences (EW) aims at improving detection of heart diseases and enhancing quality by using Bay Labs' ability to apply AI to cardiovascular imaging.

Edwards Lifesciences' Critical Care Arm Solid, THVT View Dull

Edwards Lifesciences (EW) sees strong Critical Care division sales. Management expects sluggish underlying THVT sales for 2018.

Edwards Lifesciences (EW) Up 5.6% Since Last Earnings Report: Can It Continue?

Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Edwards Lifesciences' CE Mark for SAPIEN 3 Boosts THVT Arm

Latest CE Mark receipt is expected to fortify Edwards Lifesciences' (EW) position in Europe.

Edwards Lifesciences (EW) Stock Sinks As Market Gains: What You Should Know

Edwards Lifesciences (EW) closed the most recent trading day at $149.75, moving -1.99% from the previous trading session.

The Zacks Analyst Blog Highlights: Boeing, Texas Instruments, General Dynamics, American International, TD Ameritrade and Edwards Lifesciences

The Zacks Analyst Blog Highlights: Boeing, Texas Instruments, General Dynamics, American International, TD Ameritrade and Edwards Lifesciences

Mark Vickery headshot

Top Stock Reports for Boeing, Texas Instruments & General Dynamics

Today's Research Daily features new research reports on 16 major stocks, including Boeing (BA), Texas Instruments (TXN) and General Dynamics (GD).

Edwards Lifesciences (EW) Earnings Beat, Revenues Miss in Q3

Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q3.

Tracey Ryniec headshot

The Most Spectacular Earnings Charts This Week

Investors aren't spooked in these stocks. They have great earnings track records and shares are trading near their highs.

EW, VAR Earnings Due on Oct 23: Here Are Key Predictions

Both Edwards Lifesciences (EW) and Varian Medical (VAR) are brimming with prospects despite the current political disarray within the medical instruments space.

Medidata (MDSO) Tops Earnings & Revenue Estimates in Q3

Strong performance in the Subscription revenues segment drives Medidata???s (MDSO) results in Q3. Professional services also posted steady growth.

Is a Surprise Coming for Edwards Lifesciences (EW) This Earnings Season?

Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Edwards Lifesciences (EW) Dips More Than Broader Markets: What You Should Know

Edwards Lifesciences (EW) closed the most recent trading day at $145.51, moving -1.23% from the previous trading session.

Intuitive Surgical (ISRG) Beats on Q3 Earnings & Revenues

Strong performance in the Instruments & Accessories and Systems segments drive Intuitive Surgical's (ISRG) top line in Q3.

Will Edwards' (EW) Steady Overall Growth Drive Q3 Earnings?

Edwards Lifesciences (EW) expected to gain from strength in all business segments and geographies in Q3.